Ra­tio rais­es $50M as ra­dio­phar­ma field finds its groove

Ra­dio­phar­ma­ceu­ti­cal biotech Ra­tio Ther­a­peu­tics has raised a $50 mil­lion Se­ries B to bring its first ther­a­peu­tic in­to the clin­ic, it said Wednes­day morn­ing.

The biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER